S 3991
American Made Pharmaceuticals Act of 2022
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The American Made Pharmaceuticals Act of 2022 directs the Department of Health and Human Services to establish a seven-year demonstration program to prioritize domestically manufactured drugs under Medicare, Medicaid, and the Children’s Health Insurance Program. This program, to be conducted in at least eight states, aims to encourage the production of pharmaceuticals within the United States by offering preferential treatment like reduced cost-sharing and formulary placement. The legislation focuses on ‘critical drugs’ with vulnerable supply chains and establishes criteria for eligible U.S.-based pharmaceutical companies.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.